Epidemiological characteristics of patients with Multiple Sclerosis in Kermanshah, Iran in 2012

Journal of Mazandaran University of Medical Sciences

Volumn 23, Issue 104, 2013, Pages

  Saman Nezhad, Bahareh ^a   Rezaee, Tannaz ^a   Bostani, Arash ^b   Najafi, Farid ^a   Aghaei, Abbas ^c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Multiple sclerosis; Prevalence rate

Indexed keywords

ADULT; ARTICLE; DESCRIPTIVE RESEARCH; FEMALE; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; PREVALENCE; RISK FACTOR;

EID: 84939773792     PISSN: 17359279     EISSN: 17359260     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ascherio A, Munger K. Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol 2008; 28(1): 17-28.
2. Abedidni M, Habibi Saravi R, Zarvani A, Farahmand M. Epidemiologic study of multiple sclerosis in Mazandaran, Iran, 2007. J Mazandaran Univ Med Sci 2008; 18(66): 82-6.
3. Greer JM, McCombe PA. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 2011; 234(1-2): 7-18.
4. Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004; 3(12): 709-18.
5. Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9(5): A387-A394.
6. Etemadifar M, Ashtarin F. Diagnosis and treatment of multiple sclerosis (MS). Isfahan, Iran: Four Garden Publication; 2002.
7. World Health Organization. Mental health, Neurology Disorder: public health challenges [Online]. [cited 2011]; Available from:URL: http://www.worldmsday.org/wordpress/wpcontent/ uploads/2013/05/MS_v10.pdf
8. Olek MJ. Multiple Sclerosis: Etiology, Diagnosis, and New Treatment Strategies. New York, NY: Springer; 2007.
9. Kurtzke JF. Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis. Neurol Sci 2000; 21(6): 383-403.
10. Pourmemari MH, Rabiei S, Bagheri H, Taghiloo G, Eskandari F. Epidemiologic variables in multiple sclerosis patients in Zanjan. Holistic Nursing and Midwifery 2011; 21(1): 1-6.
11. Nabavi M, Poorfarzam S, Ghasemi H. Epidemiology, clinical trend and prognosis of multiple sclerosis in 203 patients of MS clinic in Shahid Mostafa Khomeini hospital in 2002. Tehran Univ Med J 2006; 21(7): 90-7.
12. Heidari-Suresjani S, Eslami A, Hassanzadeh A. The quality of life among Multiple sclerosis patients in Isfahan, 2011. Health system Research 2011; 7(5): 571-9.
13. Ghabaae M, Qelichnia Omrani H, Roostaeizadeh M. Epidemiology of multiple sclerosis in Tehran: a three year study. Tehran Univ Med J 2007; 65(5): 74-7.
14. Page WF, Kurtzke JF, Murphy FM, Norman JE Jr. Epidemiology of multiple sclerosis in U.S. veterans: V. Ancestry and the risk of multiple sclerosis. Ann Neurol 1993; 33(6): 632-9.
15. Bostrom I, Landtblom AM, Lauer K. An ecological study of industry in a high-risk region of multiple sclerosis. J Neurol Sci 2011; 311(1-2): 50-7.
16. Ashtari F, Shaygannejad V, Heidari F, Akbari M. Prevalence of familial multiple sclerosis in Isfahan, Iran. J Isfahan Med Sch 2013; 29(138): 555-61.